Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low mBC
Comprehensive insight on clinical trials in HER2-positive and HER2-low metastatic breast cancer further investigating trastuzumab deruxtecan.
Website: https://www.onclive.com
Twitter: / onclive
Facebook: / onclive
LinkedIn: / onclive
Watch video Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low mBC online without registration, duration hours minute second in high quality. This video was added by user OncLive 30 January 2020, don't forget to share it with your friends and acquaintances, it has been viewed on our site 3,598 once and liked it 14 people.